Print Friendly, PDF & Email

Thursday, 25 April 2019

Geneva, Switzerland: The daily administration of plant-derived extracts containing a two-to-one ratio of CBD to THC is associated with a reduction in agitation and behavioral problems in patients with severe dementia, according to clinical data published in the journal Medical Cannabis and Cannabinoids.

>Read Entire Article